INS and COVID-19: Recent evidence showed that the risk of newly diagnosed DM increased after COVID-19 infection [3], and one-third of patients who had recovered from COVID-19 exhibited elevated glucose indices marked by an increase in HOMA-IR, FBG, and insulin levels [18].